Satya Marar: Populist PBM reforms are unlikely to lower drug prices

The Herald-Dispatch

Lean Left

Factuality

Ownership

Satya Marar: Populist PBM reforms are unlikely to lower drug prices

Amid rising frustrations over health care and medication costs, President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. promise to lower drug prices by targeting pharmaceutical benefit managers, or PBMs.